[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

about

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

Item

http://www.wikidata.org/entity/Q50077728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@en

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@nl

type

Item

label

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@en

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@nl

prefLabel

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@en

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@nl

P1476

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

@en

P2093

A Blaschek

http://www.w3.org/2001/XMLSchema#string

K Rostasy

http://www.w3.org/2001/XMLSchema#string

P Huppke

http://www.w3.org/2001/XMLSchema#string

T Kümpfel

http://www.w3.org/2001/XMLSchema#string

W Müller-Felber

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations

Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders.

Common viruses associated with lower pediatric multiple sclerosis risk.

Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.

Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years.

JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.

P2888

s00115-017-0422-z

P304

1377-1384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-017-0422-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29038883

http://www.w3.org/2001/XMLSchema#string

P921

adolescence